Browsing Tag
Shockwave Medical
3 posts
NYSE: JNJ Q4 earnings rise 49% to $2.10 EPS; oncology and neuroscience lead portfolio momentum
Johnson & Johnson posts $94.2B in 2025 revenue and sets $100.5B FY26 target. Find out what’s driving growth and how STELARA’s erosion could impact momentum.
Breakthrough heart study: Shockwave’s IVL therapy delivers game-changing results for women with coronary calcium buildup
Shockwave’s EMPOWER CAD study proves IVL-first PCI strategy is safe and effective in women with calcified coronary disease. Discover key findings from EuroPCR 2025.
Johnson & Johnson announces $13.1bn acquisition of Shockwave Medical to strengthen medtech division
In a monumental move within the medical technology sector, Johnson & Johnson (NYSE: JNJ) has announced its acquisition…